A 63-year-old woman with diplopia and bilateral ptosis underwent brain MRI that showed a pituitary mass with signal characteristics suggestive of adenoma. Within one week she had developed nearly complete bilateral ophthalmoplegia. A repeat MRI showed extension of the mass into both cavernous sinuses. Hypophysectomy disclosed an amelanotic melanoma. Extensive search for a primary source was unsuccessful. Despite local radiation treatment, the tumor continued to grow and the patient became blind and died within several months of diagnosis. There are seven reported cases of melanoma arising primarily in the sella turcica. Two cases of metastatic melanoma to the cavernous sinuses have been reported. Amelanotic melanoma has not been reported as a cause of cavernous sinus syndrome.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.wno.0000204665.79300.f8DOI Listing

Publication Analysis

Top Keywords

amelanotic melanoma
12
bilateral ophthalmoplegia
8
cavernous sinuses
8
melanoma
5
rapidly progressive
4
progressive bilateral
4
ophthalmoplegia enlarging
4
enlarging sellar
4
sellar mass
4
mass caused
4

Similar Publications

Introduction: The aim of this study was to differentiate amelanotic choroidal lesions - amelanotic choroidal melanoma, choroidal metastasis, and choroidal granuloma using multimodal imaging.

Methods: Retrospective comparative chart review was done. Patients diagnosed with the abovementioned choroidal lesions from 2015 to 2022 were included.

View Article and Find Full Text PDF

Anorectal malignant melanoma (ARMM) is a rare and highly aggressive type of melanoma that originates in the anorectal area. It represents a small fraction of all melanoma cases and is often associated with poor prognosis due to its late presentation and challenging treatment options. Rectal malignant melanoma typically presents with symptoms such as rectal bleeding, pain, and obstructive symptoms.

View Article and Find Full Text PDF

Plantar acral melanoma: epidemiological, clinical, dermoscopic and histopathological features. A Brazilian cohort.

An Bras Dermatol

January 2025

Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil; Dermatology Unity, Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.

Background: Acral melanomas (AM) are rare and approximately two-thirds of them occur on the soles of the feet beeing more prevalent in black and Asian individuals. Data on this subtype of melanoma are scarce in the Brazilian population.

Objectives: To describe and correlate the epidemiological, clinical, dermoscopic, and histopathological features of AM a.

View Article and Find Full Text PDF

Cyclin-Dependent Kinase Inhibitors in the Rare Subtypes of Melanoma Therapy.

Molecules

November 2024

Department of Histology and Embryology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-067 Bydgoszcz, Poland.

Melanoma occurs in various forms and body areas, not only in the cutis, but also in mucous membranes and the uvea. Rarer subtypes of that cancer differ in genomic aberrations, which cause their minor sensibility to regular cutaneous melanoma therapies. Therefore, it is essential to discover new strategies for treating rare forms of melanoma.

View Article and Find Full Text PDF

Amelanotic Melanoma-Biochemical and Molecular Induction Pathways.

Int J Mol Sci

October 2024

Department of Molecular and Cellular Biology, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, Poland.

Article Synopsis
  • * Understanding the biochemical and molecular pathways involved in AM can help develop targeted therapies, though there are currently few specific biomarkers for this type of cancer.
  • * Current treatments focus on inhibiting certain genes (like BRAF and c-KIT) and combining therapies, such as BRAF with MAK inhibitors or immune checkpoint inhibitors, to improve patient outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!